https://www.selleckchem.com/pr....oducts/Bortezomib.ht
The microbiome is emerging as a crucial player of the immune checkpoint in cancer. Melanoma is a highly immunogenic tumour, and the gut microbiome composition has been correlated to prognosis and evolution of advanced melanoma and proposed as biomarker for immune checkpoint therapy. We investigated the gut fungal and bacterial composition in early-stage melanoma and correlated microbial profiles with histopathological features. Bacterial 16S rRNA and fungal ITS region sequencing was performed from faecal samples of patients affected
Like
Comment
Share
